Advanced search×

Genetic Mapping of Glutaric Aciduria, Type 3, to Chromosome 7 and Identification of Mutations in C7orf10

Am J Hum Genet 83(5):6 (2008) PMID 18926513

While screening Old Order Amish children for glutaric aciduria type 1 (GA1) between 1989 and 1993, we found three healthy children who excreted abnormal quantities of glutaric acid but low 3-hydroxyglutaric acid, a pattern consistent with glutaric aciduria type 3 (GA3). None of these children had the GCDH c.1262C->T mutation that causes GA1 among the Amish. Using single-nucleotide polymorphism (SNP) genotypes, we identified a shared homozygous 4.7 Mb region on chromosome 7. This region contained 25 genes including C7orf10, an open reading frame with a putative mitochondrial targeting sequence and coenzyme-A transferase domain. Direct sequencing of C7orf10 revealed that the three Amish individuals were homozygous for a nonsynonymous sequence variant (c.895C->T, Arg299Trp). We then sequenced three non-Amish children with GA3 and discovered two nonsense mutations (c.322C->T, Arg108Ter, and c.424C->T, Arg142Ter) in addition to the Amish mutation. Two pathogenic alleles were identified in each of the six patients. There was no consistent clinical phenotype associated with GA3. In affected individuals, urine molar ratios of glutarate to its derivatives (3-hydroxyglutarate, glutarylcarnitine, and glutarylglycine) were elevated, suggesting impaired formation of glutaryl-CoA. These observations refine our understanding of the lysine-tryptophan degradation pathway and have important implications for the pathophysiology of GA1.

Copyright © 2008 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.ajhg.2008.09.018
Version: za2963e q8za4 q8zbb q8zc5 q8zda q8ze7 q8zfd q8zge

Similar articles you may find interesting…

  1. Advances and challenges in the treatment of branched-chain amino/keto acid metabolic defects.

    J Inherit Metab Dis 35(1):29-40 (2012) PMID 21290185

    Our focus in this review is to highlight the biochemical basis underlying recent advances and ongoing challenges of long-term conservative therapy including precursor/protein restriction, replenishment of deficient substrates, and the use of antioxidants and anaplerotic agents which refill the Krebs...
  2. Expression of neuropeptide Y, omentin and visfatin in visceral and subcutaneous adipose tissues in humans: relation to endocrine and clinica...

    Obes Facts 3(4):245-51 (2010) PMID 20823688

    We aimed at exploring the expression of neuropeptide Y (NPY), omentin and visfatin in adipose tissues of adults along with clinical parameters and hormones.
  3. Chemical evolution of the citric acid cycle: Sunlight and ultraviolet photolysis of cycle intermediates

    Orig Life Evol Biosph 19(6):603-607 (1989)